Community testing and treatment will be key to helping eliminate Hepatitis C by 2030, Dundee experts have found. Checking patients for the disease when they receive methadone treatment at smaller pharmacies will play a big part in the fight.
A study, led by Dr Christopher Byrne and Professor John Dillon at Dundee University’s School of Medicine found that nurse-delivered hepatitis c testing at community pharmacies made treatment more accessible and cure more likely, relative to conventional care, for people who use drugs.
They found that the model is well suited to smaller pharmacies and is an impor tant strategy for engaging this vulnerable patient group.
